Mani Bundle
Who owns Mani, Inc.?
Mani, Inc., a Japanese medical equipment manufacturer, was founded by Masao Matsutani in 1956. The company, now a global leader, specializes in precision medical instruments.
Understanding the ownership of Mani, Inc. is key to grasping its strategic decisions and market influence. The company's journey from a small venture to a global entity has shaped its stakeholder landscape.
Who owns Mani, Inc.?
As of August 19, 2025, Mani, Inc. has a market capitalization of $871 million, with 98.5 million shares outstanding. The company employs 4,154 individuals as of August 2024 and operates with a capital of JPY 1,087 million. Its surgical needles, a key product, hold a significant market share, with 70% in Japan and 90% in the Japanese export market, as detailed in the Mani PESTEL Analysis.
Who Founded Mani?
Mani, Inc.'s ownership journey began with its founder, Masao Matsutani, who started the business in 1956. He formally established MATSUTANI SEISAKUSYO CO., LTD. in 1959 with a focus on medical innovation, particularly rust-proof surgical needles.
| Aspect | Details |
|---|---|
| Founder | Masao Matsutani |
| Founding Year | 1956 (commenced), 1959 (formal establishment) |
| Initial Focus | Development of rust-proof surgical needles |
| Early Funding | Likely bootstrapped or founder-funded, no public record of early investors |
| Key Early Innovation | World's first 18-8 stainless steel surgical needle (1961) |
| Rebranding | MANI, INC. in 1996 for international growth |
Founder's Vision
Masao Matsutani's vision was centered on 'Differentiation' and achieving the best quality globally.
Initial Ownership
As the sole founder, Matsutani held complete initial ownership and control of the company.
Early Growth Strategy
The company experienced organic growth driven by technological advancements in its early years.
Lack of Early Investors
There is no public information indicating early external investment or significant stake acquisition by others.
Founder's Direct Control
Matsutani's direct control was crucial in shaping the company's strategic direction during its formative years.
Expansion into New Fields
The company's early success laid the foundation for expansion into dental and ophthalmic sectors.
Masao Matsutani's foundational ownership of Mani, Inc. was absolute at its inception, reflecting a singular entrepreneurial drive. While specific early shareholding percentages are not publicly disclosed, his role as the sole founder implies full initial control. The company's early trajectory, marked by innovations like the first 18-8 stainless steel surgical needle in 1961, suggests a self-funded or privately financed start, without documented early external investors. This period of organic growth and technological advancement, deeply influenced by Matsutani's commitment to Mission, Vision & Core Values of Mani, established the bedrock for the company's future diversification and international presence.
Founders and Early Ownership of Mani Company
The initial ownership structure of Mani, Inc. was entirely vested in its founder, Masao Matsutani. His vision and direct control were instrumental in the company's early development and innovation.
- Masao Matsutani established the company in 1956, formally incorporating it in 1959.
- The primary focus was on developing high-quality, rust-proof surgical needles.
- There is no public record of external investors or significant early stakeholders.
- The company's early success was driven by technological advancements and founder-led strategy.
- The transformation to MANI, INC. in 1996 signaled a strategic shift towards global expansion.
Mani SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
How Has Mani’s Ownership Changed Over Time?
Mani, Inc.'s transition to a public entity in 2012 significantly broadened its ownership landscape. The company's subsequent move to the Prime Market further solidified its position as a publicly traded firm, attracting a diverse investor base beyond its founding family.
| Stakeholder | Percentage Ownership | Number of Shares | As of Date |
|---|---|---|---|
| Datasection Inc. | 10.76% | 10,600,000 | February 27, 2025 |
| Matsutani Giken K.K. | 5.16% | 5,084,000 | February 27, 2025 |
| The Matsutani Kanji Family (Collective) | 9.906% | ||
| Sumitomo Mitsui Trust Asset Management Co., Ltd. | 3.33% | 3,277,500 | January 30, 2025 |
| The Vanguard Group, Inc. | 2.48% | 2,444,722 | April 29, 2025 |
| Nomura Asset Management Co., Ltd. | 2.46% | 2,420,100 | January 30, 2025 |
| BlackRock, Inc. | 1.70% | 1,672,400 | May 30, 2025 |
| MANI Matsutani Medical Scholarship Foundation, Endowment Arm | 3.25% | 3,200,000 | February 27, 2025 |
As of August 19, 2025, Mani, Inc. holds a market capitalization of $871 million, with 98.5 million shares outstanding. This public status has led to a diversified ownership structure, featuring significant holdings by institutional investors alongside entities presumed to be linked to the founding family, such as Matsutani Giken K.K. and the MANI Matsutani Medical Scholarship Foundation. Understanding who owns Mani company and its key stakeholders is crucial for assessing its strategic direction and governance.
Key Stakeholders in Mani, Inc.
The ownership of Mani, Inc. is distributed among various entities, reflecting its status as a publicly traded company.
- Datasection Inc. is the largest single shareholder, holding over 10% of the company's stock.
- Institutional investors like The Vanguard Group and BlackRock, Inc. represent substantial portions of the Mani company ownership.
- The founding family's influence is maintained through entities like Matsutani Giken K.K. and the MANI Matsutani Medical Scholarship Foundation.
- This diverse ownership structure impacts the company's strategic decisions and its approach to Revenue Streams & Business Model of Mani.
Mani PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
Who Sits on Mani’s Board?
Mani, Inc. has a structured corporate governance framework, established in 2004, with a board of directors designed to enhance oversight and transparency. As of August 2025, the board includes both executive and independent members, contributing diverse expertise to the company’s strategic direction.
| Director Name | Position | Key Role |
|---|---|---|
| Masaya Watanabe | Director, President and Representative Executive Officer, CEO | Chief Executive Officer |
| Masahiko Saito | Director, Executive Chairman and Chief Executive Officer | Executive Chairman |
| Kazuo Takahashi | Managing Director | |
| Toshihide Takai | Managing Director | |
| Yosuke Mitsusada | Independent Chairman | Independent Chairman |
| Tatsushi Yano | Independent Outside Director | Committee Member |
| Yukiko Moriyama | Independent Outside Director | Committee Member |
| Yukio Matsui | Independent Outside Director | Committee Member |
The board's composition is strengthened by independent outside directors who are integral to key committees, including Nominating, Compensation, and Audit. This structure is designed to ensure objective decision-making and robust oversight. The company’s adherence to standard shareholder voting rights, typical of publicly traded entities on the Tokyo Stock Exchange, suggests a commitment to equitable governance. This is further supported by a general market sentiment in 2024 opposing dual-class share structures that could dilute voting power, a principle Mani, Inc. is understood to align with. The company’s recognition with the METI Minister's Award for Corporate Governance of the Year 2023 underscores its stable and effective governance practices, indicating a lack of significant governance controversies or activist interventions.
Mani Company Governance and Stakeholder Alignment
Mani, Inc. prioritizes strong corporate governance, evidenced by its board structure and independent director involvement. This focus aims to align the interests of all Mani company stakeholders.
- Board of Directors includes executive and independent members.
- Independent directors serve on critical committees.
- Adherence to one-share-one-vote principle is typical.
- Recognition for corporate governance excellence in 2023.
Mani Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout
What Recent Changes Have Shaped Mani’s Ownership Landscape?
Over the past few years, the ownership landscape for Mani, Inc. has seen shifts in leadership, reflecting broader industry trends. Masaya Watanabe's appointment as Director, President and Representative Executive Officer, and CEO on November 25, 2024, signifies a strategic move to guide the company's future direction and growth trajectory.
| Key Personnel Change | Date | Role |
| Masaya Watanabe | November 25, 2024 | Director, President and Representative Executive Officer, and CEO |
Financially, Mani, Inc. reported a 8% year-over-year revenue increase in Q1 FY2025, driven by its surgical and eyeless needles segments, and bolstered by favorable foreign exchange rates. Despite this growth, the company experienced a decline in profitability and underperformance in its dental segment, particularly in China. Management has reiterated its FY2025 guidance, with revised consolidated earnings guidance for the full year ending August 31, 2025, announced on July 9, 2025. As of August 19, 2025, the company's stock was trading at $8.84, with a market capitalization of $871 million.
Financial Performance Highlights
Q1 FY2025 revenue saw an 8% increase year-over-year. Surgical and eyeless needles segments were key drivers of this growth.
Challenges and Outlook
Profitability declined in Q1 FY2025, with the dental segment underperforming. Management has reaffirmed its FY2025 financial guidance.
Industry Ownership Trends
The medical device industry is experiencing increased institutional ownership and a greater emphasis on ESG factors. Mani, Inc. received an MSCI ESG rating of 'A' in 2025.
Market Growth and Strategy
The broader medical device market is projected to grow, driven by technological innovations. Mani is focusing on expanding sales routes in Europe and America and developing new product categories.
Mani Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
- What is Brief History of Mani Company?
- What is Competitive Landscape of Mani Company?
- What is Growth Strategy and Future Prospects of Mani Company?
- How Does Mani Company Work?
- What is Sales and Marketing Strategy of Mani Company?
- What are Mission Vision & Core Values of Mani Company?
- What is Customer Demographics and Target Market of Mani Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.